abstract |
Compounds of formula (i)in which r1 and r2, which may be the same or different, is each selected from hydrogen or c(1-8)alkyl; r3 is aryl or aryl c(1-4)alkyl which may be optionally substituted; x is a linker group; y is an optionally substituted aryl group, and n is o,1 or 2; are inhibitors of the enzyme lp-pla2 and thereof of use in treating atherosclerosis. |